In neuroblastoma, the most frequent genetic alterations are unbalanced translocations involving chromosome 17. To gain insights into these rearrangements, we have characterized a previously identified der(1)t(1;17) of the CLB-Bar cell line. The 17q breakpoint was mapped by FISH. Subsequently, a rearranged fragment was identified by Southern analysis, cloned in a lambda vector and sequenced. The chromosome rearrangement is more complex than expected due to the presence of an interstitial 4p telomeric sequence between chromosome 1p and 17q. Three different genes, which may play a role in neuroblastoma development, are disrupted by the translocation breakpoints. Indeed, the 3 0 UTR of the PIP5K2B gene on chromosome 17q is directly fused to the (TTAGGG)n repeat of the chromosome 4p telomere, and the (1;4) fusion disrupts the MACF1 (microtubuleactin crosslinking factor 1) and POLN genes, respectively. Interestingly, the (1;4) fusion was present at diagnosis and at relapse, whereas the (4;17) fusion was detected at relapse only, leading to a secondary 17q gain confirmed by array CGH therefore indicating that 17q gain may not be a primary event in neuroblastoma. Finally, screening of a panel of neuroblastoma cell lines identified interstitial telomeric sequences in three other cases, suggesting that this may be a recurrent mechanism leading to unbalanced translocations in neuroblastoma.
In neuroblastoma, the most frequent genetic alterations are unbalanced translocations involving chromosome 17. To gain insights into these rearrangements, we have characterized a previously identified der(1)t(1;17) of the CLB-Bar cell line. The 17q breakpoint was mapped by FISH. Subsequently, a rearranged fragment was identified by Southern analysis, cloned in a lambda vector and sequenced. The chromosome rearrangement is more complex than expected due to the presence of an interstitial 4p telomeric sequence between chromosome 1p and 17q. Three different genes, which may play a role in neuroblastoma development, are disrupted by the translocation breakpoints. Indeed, the 3 0 UTR of the PIP5K2B gene on chromosome 17q is directly fused to the (TTAGGG)n repeat of the chromosome 4p telomere, and the (1;4) fusion disrupts the MACF1 (microtubuleactin crosslinking factor 1) and POLN genes, respectively. Interestingly, the (1;4) fusion was present at diagnosis and at relapse, whereas the (4;17) fusion was detected at relapse only, leading to a secondary 17q gain confirmed by array CGH therefore indicating that 17q gain may not be a primary event in neuroblastoma. Finally, screening of a panel of neuroblastoma cell lines identified interstitial telomeric sequences in three other cases, suggesting that this may be a recurrent mechanism leading to unbalanced translocations in neuroblastoma. Oncogene (2005) Keywords: neuroblastoma; chromosome 17; translocation breakpoint; molecular cloning; interstitial telomere Most malignant tumours are characterized by complex karyotypes with numerous balanced and unbalanced chromosome translocations. Balanced translocations are frequently observed in haematological malignancies and in some types of sarcoma. They usually lead to the activation or disruption of genes located at the vicinity of the breakpoints, or to the generation of fusion genes (Greaves and Wiemels, 2003) . In contrast, the consequences of unbalanced translocations at a molecular level are less well understood. In addition to breakpointrelated gene alterations, they also lead to chromosome arm copy-number changes. These may therefore contribute to oncogenesis by the gain of genetic material containing tumour growth-promoting genes, and the loss of genetic material encoding tumour suppressor genes.
In neuroblastoma, the most frequent genetic alterations are unbalanced translocations between chromosome 17 and various partners, most frequently chromosomes 1p, 3p and 11q, leading to deletion of part the recipient chromosome, and to gain of chromosome arm 17q (Bown, 2001; Brodeur, 2003) . This last alteration occurs in 50-70% of cases, and is thought by most authors to constitute an indicator of adverse outcome (Bown et al., 1999; Lastowska et al., 2001 Lastowska et al., , 2002 . Other studies have suggested that 17q gain may not be associated with poor outcome (Spitz et al., 2003) .
In neuroblastoma, the positions of the breakpoints along chromosome 17 are highly heterogeneous, and several distinct 17q translocations may occur within one tumour (Meddeb et al., 1996; Schleiermacher et al., 2003) . This strongly suggests that the supposed oncogenic role of these translocations may rely on an increased dosage of genes located distally on 17q, together with the haploinsufficiency of genes encoded by the deleted arm of the recipient chromosome.
The mechanism leading to these translocations is not well understood. They are thought to arise in the S/G2 phase, and a particular occurrence within early replicating chromosome regions has been observed (Caron et al., 1994; Schleiermacher et al., 2003) . However, up to now, no study has investigated the molecular structure of the breakpoints. Such an analysis may provide insight into the mechanisms leading to these translocations, and may possibly highlight an underlying defect of a chromosome maintenance pathway. In order to address this issue, we have cloned the breakpoint of an unbalanced chromosome 17q translocation previously identified as a der(1)t(1;17) in CLBBar. This cell line was established from a neuroblastoma tumour at the time of relapse. The patient, a 2-year-old girl, had been treated by conventional (cyclophosphamide/adriamycin/vincristine and etoposide/cisplatin regimen) as well as high-dose chemotherapy (busulphan/ melphalan regimen) and local irradiation for a stage 4 abdominal neuroblastoma. Constitutional DNA, tumour DNA obtained from the primary at the time of diagnosis and DNA of the cell line CLB-Bar-LT established from the same tumour at diagnosis, as well as DNA from the tumour at the time of relapse were also available and allowed a chronological analysis of events leading to the chromosome rearrangement.
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In CLB-Bar, the chromosome 17 breakpoint mapped to a region flanked proximally by the marker D17S946 and distally by the clone RP11-56K13 ( Figure 1a ) (Schleiermacher et al., 2004) . To map the breakpoint more precisely, high-resolution FISH was performed, localizing the breakpoint to a region bordered proximally and distally by probes corresponding to the PSMB3 and PIP5K2B genes, respectively ( Figure 1a ). This region was subsequently explored by Southern analysis (Figure 1a and b). A 1.5 kb probe (S1.Bar17), located within the terminal exon of the PIP5K2B gene, detected a genomic DNA rearrangement in the CLB-Bar DNA with 14 different restriction enzyme digests. In all digests, the tumour-specific band was larger than the germline fragment, suggesting that the rearranged fragment had a particular structure, which precluded its enzymatic digest. The smallest rearranged fragment of approximately 8 kb, as compared to the corresponding 4 kb germline fragment, was detected with the SacI digest and was cloned in the lambda ZAPII vector.
The resulting library was screened with the S1.Bar17 probe, and three recombinant positive clones were isolated. Sequencing of these clones showed that the breakpoint on chromosome 17 was localized within the PIP5K2B gene ( Figure 1c) . Surprisingly, this 17q region was not fused to a chromosome 1 sequence but to a telomeric (TTAGGG) repeat. Full sequencing of the recombinant clones enabled to assign unambiguously this sequence to the 4p telomere. The presence of approximately 6.5 kb of telomeric (TTAGGG) repeats resulted in the absence of restriction sites and accounted for the results of the Southern blot experiments.
A similar cloning strategy was undertaken to characterize the (1;4) junction of this complex chromosome rearrangement ( Figure 2a ). The breakpoint was mapped to a region of approximately 23 kb within BAC clone RP11-318G6. Southern analysis using the S5.Bar4 probe detected a rearranged fragment in the EcoRI, KpnI and ScaI digests (data not shown). The 4.3 kb ScaI rearranged fragment was cloned into the EcoRI restriction site of the Lambda ZAP Express vector using an EcoRI adaptor. Sequencing of a positive clone revealed that the breakpoint on proximal chromosome 4p was located within a LINE sequence of the POLN gene ( Figure 2b ). On chromosome 1, the breakpoint was located within an intron of the very large MACF1 (microtubule-actin crosslinking factor 1) gene, in a region devoid of repetitive sequences. No significant sequence homologies or structural features were detected upstream and downstream of the chromosome 4 and chromosome 1 breakpoints.
These results indicate that the chromosome rearrangement is more complex than expected, with an interstitial 4p telomere present between chromosomes 1p and 17q. The complex rearrangement presents three striking features. Figure 1 Cloning of the chromosome 17q breakpoint in CLB-Bar. Mapping by FISH was performed using BACs, PACs or PCR products. BAC/PAC clones were purchased from Research Genetics (http://www.resgen.com) or from BACPAC Resources (http:// www.chori.org). DNA was extracted according to standard procedures and directly labelled with a fluorochrome by nick translation using the Bionick Labeling kit (Invitrogen). For fine mapping, DNA probes of 5-8 kb were designed according to the known sequence of the Human Genome Browser (HGB; http://genome.ucsc.edu/, version May 2004). PCR products were generated by long-range PCR using the Expand Long Template PCR system (Roche). The DNA was directly labelled with a fluorochome and used in FISH experiments. For subsequent Southern analysis, genomic DNA was digested with the appropriate restriction enzyme, separated by gel electrophoresis and transferred to Hybond-N þ membranes (Amersham). The blots were hybridized with radioactively labelled probes according to standard procedures (Sambrook and Russel, 2000) . For the cloning of rearranged DNA fragments, 10 mg of genomic DNA were digested with the appropriate restriction enzyme and run through a 0.8% agarose gel. A portion of the gel corresponding to the size of the rearranged DNA fragment was isolated. The precipitated DNA was ligated to the Lambda ZAPII or Lambda ZAP Express vector (Stratagene), using an insert/vector ratio of 5/1. The library was plated onto agar plates, and screening was performed according to standard procedures (Sambrook and Russel, 2000) . Positive clones were isolated and a pBluescript or pBK-CMV phagemid containing the insert of interest excised in vivo using the Exassist Helper Phage provided by the manufacturer (Stratagene). DNA sequencing was performed with the ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kit, using the T3 and T7 universal primers. Sequence data were analysed using the EditView program. (a) In CLB-Bar, the 17q breakpoint mapped within 17q12 to a region bordered by the marker D17S946 proximally and the clone RP11-56K13 distally (Schleiermacher et al., 2004) . The positions on the HGB are indicated in Mb. This region was further refined by FISH using PCR-generated probes. The names of known genes are indicated on the left, and PCR probes used for FISH located within these genes are indicated according to their position on the HGB. Probes that hybridized to the translocated chromosome 17q are indicated by black circles, whereas negative probes are shown in white. The lower panel indicates the restriction map of the 14 kb breakpoint region flanked proximally and distally by the PSMB3 and PIP5K2B probes, respectively. The position of the S1. remodelling and in the structure of focal adhesion plaques by interaction with talin (Di Paolo et al., 2002; Yamazaki et al., 2002) . To date, little is known about the specific function of PIP5K2B, but it has been shown that the PIP5K2B protein interacts specifically with the juxtamembrane region of the p55 TNF receptor, and that its activity may be regulated by TNF-alpha (Castellino et al., 1997) . On chromosome 4p, the breakpoint disrupts the POLN/POL4P gene, which encodes a DNA-directed DNA polymerase (Marini et al., 2003) . The chromosome 1 breakpoint disrupts the MACF1 gene, a recently described member of the plakin family, which encode proteins characterized by their ability to form bridges between different cytoskeletal elements by specialized modular domains (Gong et al., 2001) . These two genes are fused in the opposite transcriptional orientation and are therefore not expected to lead to fusion transcripts and proteins. Further studies of these three genes should enable to document whether the disruption of these genes is coincidental or if it may play a role in the development of neuroblastoma through haploinsufficiency or synthesis of truncated proteins with potential dominantnegative roles. It is noteworthy that none of these three genes has been previously shown to be involved in the oncogenesis of neuroblastoma. In particular,
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Chr1p34.3 Figure 3 Schematic representation of the complex rearrangement identified as a der (1) der (9) 9 9 der (4) 4 der (7) 7 der(1) Figure 4 Interstitial telomeric sequences in neuroblastoma cell lines detected with telomere-specific probes. Screening for interstitial telomeric sequences was performed using a commercially available digoxigenine-labelled (TTAGGG)n probe (Oncor), and/or a (TTAGGG)4 peptide nucleic acid probe labelled directly with FITC (Dako). The origin of detected interstitial telomeres was confirmed by bicolour FISH using subtelomeric BACs/PACs (data not shown). (a) Interstitial 4p telomere of the der(1)t(1;4;17) in the CLB-Bar cell line, (b) interstitial 4p telomere of the der(4)t(1;4)(p12;ptel) in the CHP212 cell line, (c) interstitial 9q telomere in the der(9)t(2;9)(p21;qtel) and (d) interstitial 7q telomere in the der(7)t(1;7)(q31;qtel) in the SK-N-SH cell line In CLB-Bar, in addition to the 1p loss and distal 4p gain, a chromosome 17q gain from 34 Mb to 17qtel can be seen, consistent with the position of the 17q breakpoint they do not correspond to genes identified in the vicinity of constitutional translocations (Roberts et al., 1998; Sossey-Alaoui et al., 2002; Van Roy et al., 2002) . The second striking feature of the complex chromosome rearrangement is the presence of an interstitial 4p telomere sequence between the 17q and 1p breakpoints (Figure 3) , confirmed by FISH using a subtelomeric 4p-specific probe (RP1-36P21) and a (TTAGGG)n probe (Figure 4a) .
The interstitial chromosome 4p was not detected in conventional cytogenetic or 24-colour karyotyping studies of the CLB-Bar cell line due to its size of 2 Mb, which is below the limit of resolution of these techniques (Schleiermacher et al., 2003) . Interstitial telomeric signals were searched for in 18 other neuroblastoma cell lines (SK-N-FI, SK-N-BE, SK-N-AS, SK-N-SH, SK-N-DZ, SJNB-1, SJNB-6, SJNB-8, SJNB-12, CLB-MA, CLB-Tr, CHP212, 106C, TR14, KCNR, IMR32, GIMEN, LAN1) harbouring a total of 94 unbalanced chromosome translocations. Interstitial telomeric sequences were detected in three cell lines (Figure 4a-d) . This number may be underevaluated since screening by FISH with telomeric probes may not be sensitive enough to reveal interstitial telomeric sequences with a small number of repeats. Further studies, and particularly cloning of other translocation breakpoints, should more precisely establish the frequency of these telomere rearrangements and explore the hypothesis of a defective telomere maintenance pathway as a key event in the development of neuroblastoma (Zhu et al., 2003) .
The third striking feature of this (1;4;17) rearrangement concerns its stepwise occurrence, leading to the progressive acquisition of the two most frequent abnormalities of neuroblastoma, 1p loss and 17q gain. Indeed, the availability of material obtained at diagnosis and at relapse enabled us to determine the chronology leading to this complex rearrangement.
PCR assays targeting the (4;17) and (1;4) fusions were used to analyse constitutional and tumour DNAs, including DNA from the primary tumour and a derived cell line at the time of diagnosis (CLB-Bar-LT), as well as DNA from the tumour at the time of relapse and the corresponding cell line CLB-Bar. These analyses showed that the (1;4) fusion was present in all samples except the constitutional DNA, indicating that this fusion was an early somatic rearrangement (Figure 5a ). In contrast, the (4;17) fusion was detected only in the material obtained at the time of relapse. These findings were confirmed by array-CGH and microsatellite analysis. For initial samples, array-CGH revealed deletion of chromosome 1p, gain of distal chromosome 4p and a normal profile for chromosome 17. These results are consistent with the presence of one normal chromosome 1, two normal chromosomes 4, two normal chromosomes 17 and a der(1)t(1;4)(p34;p16) ( Figure 5b) . Samples obtained at the time of relapse revealed deletion of chromosome 1p, gain of distal chromosome 4p and gain of chromosome 17q, consistent with the presence of one normal chromosome 1, two normal chromosomes 4, two normal chromosomes 17 and a der(1)t(1;4;17), as evidenced by 24-colour karyotyping (Schleiermacher et al., 2003) . Moreover, microsatellite analysis revealed loss of heterozygosity at distal loci on chromosome 1p, and allelic imbalance consistent with gain of chromosome 4p, in all samples but the constitutional DNA. Samples obtained at diagnosis showed balanced alleles for all chromosome 17 loci, whereas allelic imbalance at 17q loci, consistent with the gain of chromosome 17q, was observed in samples obtained at relapse.
Altogether, these results indicate that the alterations were somatically acquired since none of them were observed at the constitutional level and were not due to cell culture artefacts, since the study of cell lines was fully consistent with that of matched snap-frozen tumour material. The primary tumour was characterized by a der(1)t(1;4)(p34;p16) translocation, leading to deletion of the 1p36 fragment, which is suspected to harbour one or several putative neuroblastoma tumour suppressor genes, and the gain of 4p16, a region thought to encode a neuroblastoma susceptibility gene involved in rare familial cases (Perri et al., 2002) . At the time of relapse, an unbalanced translocation was detected between the der(1) and chromosome 17 with gain of chromosome arm 17q, the most frequent chromosome alteration in neuroblastoma. A chromosome 17 alteration occurring at the time of relapse has been described in a cytogenetic analysis (Christiansen et al., 1987) . Furthermore, clonal variations of 17q copy number have been detected in FISH studies, suggesting that these alterations may be secondary events in neuroblastoma (Trakhtenbrot et al., 2002) . In our study, the der(1)t(1;4;17) may either have existed at the time of diagnosis as a rare subclone or may have occurred later, possibly induced by antineoplastic treatment.
In conclusion, our findings show that the deletion of chromosome 1 may precede the gain of chromosome 17q, which may therefore be a late rather than an initiating event in neuroblastoma development, and which may confer an additional selective advantage.
